James E. Oneill serves as Executive at Cerulean Pharma Inc., where they oversee executive responsibilities. Since joining the company, James E. Oneill has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 31, 2015 involved receiving (via award) 1,098 shares valued at $2.6K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 31, 2015 | CERU | $2.6K | Award | 1,098 | $2.38 | Discretionary |
James E. Oneill currently holds 2,098 shares of Cerulean Pharma Inc. (CERU), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James E. Oneill has been a net neutral trader of CERU stock. They have purchased $0 and sold $0 worth of shares.
James E. Oneill's most recent insider trade was on Dec 31, 2015, when they sold 1,098 shares at $2.38 per share.
Get notified when new Form 4 filings are submitted